269 related articles for article (PubMed ID: 15147951)
1. Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate.
Kuo CJ; Chi YH; Hsu JT; Liang PH
Biochem Biophys Res Commun; 2004 Jun; 318(4):862-7. PubMed ID: 15147951
[TBL] [Abstract][Full Text] [Related]
2. A continuous fluorescence-based assay of human cytomegalovirus protease using a peptide substrate.
Holskin BP; Bukhtiyarova M; Dunn BM; Baur P; de Chastonay J; Pennington MW
Anal Biochem; 1995 May; 227(1):148-55. PubMed ID: 7668375
[TBL] [Abstract][Full Text] [Related]
3. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer.
Matayoshi ED; Wang GT; Krafft GA; Erickson J
Science; 1990 Feb; 247(4945):954-8. PubMed ID: 2106161
[TBL] [Abstract][Full Text] [Related]
4. Characterization of SARS-CoV main protease and identification of biologically active small molecule inhibitors using a continuous fluorescence-based assay.
Kao RY; To AP; Ng LW; Tsui WH; Lee TS; Tsoi HW; Yuen KY
FEBS Lett; 2004 Oct; 576(3):325-30. PubMed ID: 15498556
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic activity characterization of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer technique.
Chen S; Chen LL; Luo HB; Sun T; Chen J; Ye F; Cai JH; Shen JK; Shen X; Jiang HL
Acta Pharmacol Sin; 2005 Jan; 26(1):99-106. PubMed ID: 15659121
[TBL] [Abstract][Full Text] [Related]
6. Single-chain recombinant human cytomegalovirus protease. Activity against its natural protein substrate and fluorogenic peptide substrates.
Pinko C; Margosiak SA; Vanderpool D; Gutowski JC; Condon B; Kan CC
J Biol Chem; 1995 Oct; 270(40):23634-40. PubMed ID: 7559530
[TBL] [Abstract][Full Text] [Related]
7. Development of a red-shifted fluorescence-based assay for SARS-coronavirus 3CL protease: identification of a novel class of anti-SARS agents from the tropical marine sponge Axinella corrugata.
Hamill P; Hudson D; Kao RY; Chow P; Raj M; Xu H; Richer MJ; Jean F
Biol Chem; 2006 Aug; 387(8):1063-74. PubMed ID: 16895476
[TBL] [Abstract][Full Text] [Related]
8. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro.
Chen L; Gui C; Luo X; Yang Q; Günther S; Scandella E; Drosten C; Bai D; He X; Ludewig B; Chen J; Luo H; Yang Y; Yang Y; Zou J; Thiel V; Chen K; Shen J; Shen X; Jiang H
J Virol; 2005 Jun; 79(11):7095-103. PubMed ID: 15890949
[TBL] [Abstract][Full Text] [Related]
9. A continuous fluorimetric assay for tail-specific protease.
Beebe KD; Pei D
Anal Biochem; 1998 Oct; 263(1):51-6. PubMed ID: 9750142
[TBL] [Abstract][Full Text] [Related]
10. Mutational and inhibitive analysis of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer-based assays.
Kuang WF; Chow LP; Wu MH; Hwang LH
Biochem Biophys Res Commun; 2005 Jun; 331(4):1554-9. PubMed ID: 15883050
[TBL] [Abstract][Full Text] [Related]
11. Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS.
Tomar S; Johnston ML; St John SE; Osswald HL; Nyalapatla PR; Paul LN; Ghosh AK; Denison MR; Mesecar AD
J Biol Chem; 2015 Aug; 290(32):19403-22. PubMed ID: 26055715
[TBL] [Abstract][Full Text] [Related]
12. Critical assessment of important regions in the subunit association and catalytic action of the severe acute respiratory syndrome coronavirus main protease.
Hsu WC; Chang HC; Chou CY; Tsai PJ; Lin PI; Chang GG
J Biol Chem; 2005 Jun; 280(24):22741-8. PubMed ID: 15831489
[TBL] [Abstract][Full Text] [Related]
13. Severe acute respiratory syndrome coronavirus 3C-like proteinase N terminus is indispensable for proteolytic activity but not for enzyme dimerization. Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations.
Chen S; Chen L; Tan J; Chen J; Du L; Sun T; Shen J; Chen K; Jiang H; Shen X
J Biol Chem; 2005 Jan; 280(1):164-73. PubMed ID: 15507456
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic activation of recombinant pro-memapsin 2 (pro-beta-secretase) studied with new fluorogenic substrates.
Ermolieff J; Loy JA; Koelsch G; Tang J
Biochemistry; 2000 Oct; 39(40):12450-6. PubMed ID: 11015226
[TBL] [Abstract][Full Text] [Related]
15. Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease.
Shie JJ; Fang JM; Kuo CJ; Kuo TH; Liang PH; Huang HJ; Yang WB; Lin CH; Chen JL; Wu YT; Wong CH
J Med Chem; 2005 Jun; 48(13):4469-73. PubMed ID: 15974598
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors.
Chen LR; Wang YC; Lin YW; Chou SY; Chen SF; Liu LT; Wu YT; Kuo CJ; Chen TS; Juang SH
Bioorg Med Chem Lett; 2005 Jun; 15(12):3058-62. PubMed ID: 15896959
[TBL] [Abstract][Full Text] [Related]
17. Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease.
Zhu L; George S; Schmidt MF; Al-Gharabli SI; Rademann J; Hilgenfeld R
Antiviral Res; 2011 Nov; 92(2):204-12. PubMed ID: 21854807
[TBL] [Abstract][Full Text] [Related]
18. A general method for the preparation of internally quenched fluorogenic protease substrates using solid-phase peptide synthesis.
Maggiora LL; Smith CW; Zhang ZY
J Med Chem; 1992 Oct; 35(21):3727-30. PubMed ID: 1433187
[TBL] [Abstract][Full Text] [Related]
19. Quaternary structure of the severe acute respiratory syndrome (SARS) coronavirus main protease.
Chou CY; Chang HC; Hsu WC; Lin TZ; Lin CH; Chang GG
Biochemistry; 2004 Nov; 43(47):14958-70. PubMed ID: 15554703
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the 3C-like protease activity of SARS-Coronavirus: recommendations for standardized assays for drug discovery.
Grum-Tokars V; Ratia K; Begaye A; Baker SC; Mesecar AD
Virus Res; 2008 Apr; 133(1):63-73. PubMed ID: 17397958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
